Dr. Ali Taher

Research focus: various hemoglobinopathies, especially thalassemia.
450 articles published in leading peer-reviewed international journals & over 100 abstracts accepted in international meetings, most on thalassemia.
Editor of several books, including 2 books that have set the new guidelines in the management of Transfusion Dependent Thalassemia (TDT) as well as Non-Transfusion- Dependent Thalassemia (NTDT).
Principal investigator on key clinical trials evaluating the efficacy and safety of iron chelation therapy in TDT and NTDT while I continue to evaluate new treatment strategies and chelators to help achieve optimal control of iron overload in these patient populations.
Founder &/or member of different local and regional scientific interest groups and associations that promote partnerships in science and dissemination of knowledge to both physicians and the community